# Phase Five Completion Report — Genome Evolvability

## Status

**Phase Five is complete, subject to final repository merge/CI.**

Phase Five asked a deliberately narrow question:

> Can Melakat remove the fixed-length genome ceiling and support blind, heritable genome-length variation without rewarding larger genomes or predefining complexity?

The completed evidence supports **yes** for the implemented model. It does not establish increasing complexity, adaptation, intelligence, or open-ended evolution.

## Why Phase Five was necessary

Before Phase Five, Melakat could mutate instruction opcodes but genome length was structurally fixed. The original minimal replicator encoded its own length in the copy loop and used absolute jump addresses, making naive insertion/deletion a brittle representation change rather than a fair test of evolvability.

Phase Five therefore changed the evolvable substrate before enabling structural mutation. Older Phase Zero–Four engines and accepted evidence remain separate and unchanged.

## Gate 5A — Length-robust replication substrate

PR #31 introduced a Phase-Five-only backend with:

- `COPY_NEXT`: sequentially copies one instruction from the organism's own current genome;
- a dynamic daughter replication buffer;
- `NOP_A` / `NOP_B` neutral template symbols;
- `JUMP_TEMPLATE` and `JUMP_TEMPLATE_IF_ZERO` for template-relative flow control;
- explicit division only after a complete self-copy;
- an ancestor that contains neither a hard-coded genome length nor an absolute replication-loop target.

Gate 5A versions:

- world contract: `phase-five-evolvability-0.1`
- engine: `phase-five-vm-0.1`
- measurement: `phase-five-measurement-0.1`

The Phase Five VM is separate from the frozen earlier VM paths.

## Gate 5B — Blind structural mutation mechanics

PR #32 added an opt-in structural mutation channel while preserving Gate 5A semantics when structural mutation is not configured.

The first structural operators are intentionally minimal:

- **single-instruction tandem duplication**: copies an existing instruction together with its existing operands, producing exact length delta `+1`;
- **single-instruction deletion**: deletes one existing instruction, producing exact length delta `-1` when the genome has more than one instruction.

No instruction is protected from deletion. The host does not label instructions as essential or beneficial.

The structural mutation contract applies at most one event to one daughter proposal. Mutation order is:

1. organism completes self-copy;
2. blind opcode substitution is applied;
3. at most one structural event is applied using an independent deterministic structural RNG stream;
4. the resulting daughter genome is held stable while ordinary energy/memory reproduction checks are resolved.

The structural RNG is versioned as `phase-five-structural-rng-0.1`.

Gate 5B evidence versions:

- engine: `phase-five-vm-0.2`
- measurement: `phase-five-measurement-0.2`

## Natural costs; no complexity reward

Phase Five does not add a genome-size fitness term.

Genome size is already coupled to real substrate costs:

- structural memory allocation includes genome length;
- every copied instruction requires replication work;
- VM execution has explicit energy cost;
- finite world memory can block reproduction.

A longer genome is therefore not rewarded for being longer. A shorter genome is not rewarded merely for shrinking. Any persistent size variant must survive the same computation, memory, energy, and reproduction rules.

Genome length is recorded as a structural measurement, **not** as a complexity score.

## Gate 5C — Exposure-only calibration

The calibration specification is:

`experiments/phase-five/structural-event-rate-calibration.json`

Configuration:

- 8 matched seeds;
- 1000 ticks per run;
- homogeneous non-spatial Phase Five world;
- substitution rate `0.01`;
- balanced structural event type probability (`0.5` duplication / `0.5` deletion);
- candidate structural event rates: `0.01`, `0.025`, `0.05`, `0.10`.

The rate-selection rule was registered before results were inspected. The selected rate had to be the **lowest** candidate satisfying all of:

- at least 16 committed structural events across the 8 runs;
- at least 6/8 runs with at least one committed structural event;
- at least 4 committed duplications;
- at least 4 committed deletions;
- experiment validation and deterministic replay pass.

Genome expansion, population, reproduction, lineage persistence, survival, or any desirable scientific outcome were forbidden as calibration-selection criteria.

### Calibration result

| Structural event rate | Committed events | Exposed runs | Duplications | Deletions | Exposure gate |
| ---: | ---: | ---: | ---: | ---: | --- |
| `0.01` | 11 | 6/8 | 6 | 5 | FAIL |
| `0.025` | 26 | 7/8 | 12 | 14 | **PASS — selected** |
| `0.05` | 50 | 8/8 | 23 | 27 | PASS |
| `0.10` | 83 | 8/8 | 37 | 46 | PASS |

The full-campaign event rate was therefore frozen at **`0.025`** before Gate 5D was run.

Calibration validation passed and the configured deterministic replay was identical.

## Gate 5D — Full matched-seed variable-genome campaign

Frozen specification:

`experiments/phase-five/variable-genome-full.json`

Design:

- 30 matched seeds;
- 2 conditions;
- 2000 ticks per run;
- 60 primary runs total;
- identical Phase Five representation, substitution mutation, energy, memory, execution, and reproduction rules;
- balanced duplication/deletion probability `0.5` in both configurations;
- only intended causal difference: structural event rate.

Conditions:

- `structural-off`: `mutation.structural_event_rate = 0.0`
- `structural-balanced-on`: `mutation.structural_event_rate = 0.025`

## Integrity result

The full evidence gate passed:

- completed primary runs: **60/60**;
- validation failures: **0**;
- deterministic replay: **PASS / identical**;
- control committed structural events: **0**;
- treatment committed structural events: **97**;
- treatment runs exposed to a committed structural event: **29/30**;
- treatment duplications: **42**;
- treatment deletions: **55**;
- maximum absolute energy-balance error: **`4.36e-08`**, below the accepted `1e-07` tolerance.

## Central evolvability result

The required heredity gate passed:

- variable-length births in treatment: **61**;
- treatment variable-length organisms that later reproduced: **12**;
- treatment runs ending with at least one active variable-length organism: **14/30**;
- control structural events: **0**.

Thus structural mutation did not merely create transient malformed daughters. Some length variants were born, remained executable long enough to reproduce, and transmitted descendants under the ordinary resource constraints of the model.

This is evidence for **heritable variable genome length** and therefore for the specific structural evolvability mechanism targeted by Phase Five.

## Genome-length outcomes

The ancestor length is `14` instructions.

At the end of control runs:

- active minimum length: `14`;
- active maximum length: `14`;
- distinct active lengths: always `1`;
- active genome-length variance: `0`.

Across treatment runs:

- observed active minimum reached `13`;
- observed active maximum reached `15`;
- maximum distinct active lengths within a run reached `3`;
- mean number of distinct active lengths: `1.5667` versus `1.0` control;
- mean active genome length remained approximately unchanged: `13.9981` versus `14.0` control.

Matched-seed approximate 95% intervals that excluded zero included:

- `distinct_genome_lengths`: delta `+0.5667`, interval `[0.3237, 0.8096]`;
- `genome_length_maximum`: delta `+0.3000`, interval `[0.1332, 0.4668]`;
- `genome_length_minimum`: delta `-0.2667`, interval `[-0.4276, -0.1057]`;
- `genome_length_variance`: delta `+0.01629`, interval `[0.00790, 0.02468]`;
- `variable_length_births`: delta `+2.0333` per run, interval `[1.4504, 2.6163]`;
- `variable_length_reproducing_offspring`: delta `+0.4000` per run, interval `[0.1088, 0.6912]`;
- `variable_length_active_population`: delta `+0.9000`, interval `[0.4363, 1.3637]`.

The mean length itself did not materially shift. This is an important result: the intervention opened a heritable length dimension without simply forcing monotonic genome expansion.

## Cost and ecological observations

`replication_copy_operations` was the registered cost endpoint with a paired interval excluding zero:

- control mean: `1431.33`;
- treatment mean: `1451.63`;
- delta: `+20.30`;
- approximate 95% interval: `[8.91, 31.69]`.

This is consistent with structural variants changing realized copying workload. It should not be interpreted as a benefit.

Several secondary diversity/turnover endpoints also differed in treatment:

- active genotype count: `1.8667 -> 2.5333`;
- active lineage count: `1.8 -> 2.4`;
- historical genotype count: `6.5 -> 8.3333`;
- births: `46.8 -> 47.9333`;
- deaths: `4.8 -> 5.9333`;
- faults: `3.9667 -> 5.0`.

Active population remained `54` in both conditions at the final measurement because the configured memory-limited world saturated at that scale. These secondary results describe the current campaign and are not evidence of greater biological fitness or complexity.

## What Phase Five establishes

Phase Five establishes, for this implemented model and evidence regime:

1. a replication representation that does not encode its own genome length or use absolute replication-loop addresses;
2. blind single-instruction duplication and deletion on an independent deterministic RNG stream;
3. reproducible creation of both shorter and longer genomes;
4. inheritance of variable genome length through ordinary reproduction;
5. reproduction by some variable-length organisms;
6. measurable structural diversity with real memory/copy/execution constraints;
7. a fully archived, matched-seed, validated evidence gate.

## What Phase Five does **not** establish

It does **not** establish:

- increasing functional complexity;
- that longer genomes are better;
- adaptation;
- fitness advantage;
- intelligence;
- innovation in an open-ended sense;
- open-ended evolution;
- multicellularity;
- cooperation, predation, or communication.

In particular:

> **Variable genome length is not equivalent to increasing complexity.**

Future complexity claims require separately defined functional/algorithmic/behavioral measurements that do not reward genome size by construction.

## Evidence archive

Calibration:

`results/phase-five/structural-event-rate-calibration/`

Full evidence:

`results/phase-five/variable-genome-full/`

The full archive contains:

- `campaign.json`
- `runs.csv`
- `summary.json`
- `comparison.csv`
- `validation.json`
- `provenance.json`
- `paired-analysis.json`
- `campaign-verification.json`
- `merge-readiness.json`
- `SHA256SUMS.txt`

The evidence workflow also produced an immutable GitHub Actions artifact for the campaign run.

## Completion decision

The Phase Five merge-readiness gate passed because:

- all 60 primary runs completed;
- validation and deterministic replay passed;
- energy accounting remained within tolerance;
- the control had zero structural events;
- the treatment produced both duplications and deletions;
- variable-length births occurred;
- variable-length organisms themselves reproduced.

**Phase Five is therefore scientifically complete for the registered genome-evolvability question.**
